Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Current Leases (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Current Leases for 17 consecutive years, with $51000.0 as the latest value for Q1 2026.

  • Quarterly Current Leases fell 10.53% to $51000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $51000.0 through Mar 2026, down 10.53% year-over-year, with the annual reading at $61000.0 for FY2025, 10.91% up from the prior year.
  • Current Leases for Q1 2026 was $51000.0 at Achieve Life Sciences, down from $61000.0 in the prior quarter.
  • The five-year high for Current Leases was $63000.0 in Q4 2023, with the low at $22000.0 in Q3 2024.
  • Average Current Leases over 5 years is $51529.4, with a median of $58000.0 recorded in 2022.
  • The sharpest move saw Current Leases plummeted 66.67% in 2022, then skyrocketed 168.18% in 2025.
  • Achieve Life Sciences' Current Leases stood at $58000.0 in 2022, then grew by 8.62% to $63000.0 in 2023, then fell by 12.7% to $55000.0 in 2024, then rose by 10.91% to $61000.0 in 2025, then decreased by 16.39% to $51000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Current Leases are $51000.0 (Q1 2026), $61000.0 (Q4 2025), and $59000.0 (Q3 2025).